Maryette L Sabater, MD
Family Practice · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 057004 · Eden Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sabater’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A126396 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$34,315
Medicare paid this office $34,315 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 78 | $19,451 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $5,129 | $155 |
| Short return visit (20+ min) | 16 | $1,045 | $65 |
| Influenza vaccine, inactivated | 11 | $900 | $82 |
| Administration of influenza virus vaccine | 12 | $464 | $39 |
See all 7 services
| Return visit (30+ min) | 78 | $19,451 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $5,129 | $155 |
| Short return visit (20+ min) | 16 | $1,045 | $65 |
| Influenza vaccine, inactivated | 11 | $900 | $82 |
| Administration of influenza virus vaccine | 12 | $464 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 14 | $222 | $12 |
| Automated urinalysis test | 20 | $48 | $2 |
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 73 · Women 76% · Also on Medicaid 20% · Health risk score 1.31. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Diabetes 39% · Chronic kidney disease 25% · Coronary heart disease 17% · Cancer 16% · Depression 16% · Heart failure 13% · COPD 12% · Atrial fibrillation 12%.
The office billed $109,955, Medicare allowed $44,112 and paid $34,315; for 380 services of 32 kinds; $4,077 of it was for drugs given in the office and $30,238 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 380 | 73 | 1.31 | $109,955 | $34,315 |
| 2023 | 85 | 293 | 74 | 1.21 | $84,545 | $29,351 |
| 2022 | 94 | 294 | 75 | 1.63 | $84,268 | $29,141 |
| 2021 | 96 | 304 | 73 | 1.31 | $85,041 | $29,134 |
| 2020 | 122 | 244 | 71 | 1.49 | $67,226 | $21,676 |
| 2019 | 85 | 229 | 72 | 1.34 | $54,490 | $16,350 |
| 2018 | 29 | 66 | 74 | 1.39 | $11,049 | $3,905 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 58 | $15,531 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $6,104 | $157 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 15 | $1,137 | $76 |
| Administration of influenza virus vaccine | 16 | $594 | $37 |
2022: 4 services
| Return visit (30+ min) | 74 | $18,816 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,300 | $156 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | $773 | $70 |
| Administration of influenza virus vaccine | 13 | $476 | $37 |
2021: 5 services
| Return visit (30+ min) | 73 | $18,682 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $3,964 | $159 |
| Short return visit (20+ min) | 14 | $1,129 | $71 |
| Influenza vaccine split virus, preservative free | 13 | $844 | $65 |
| Administration of influenza virus vaccine | 15 | $317 | $21 |
2020: 4 services
| Return visit (30+ min) | 58 | $8,904 | $96 |
| New patient visit (45+ min) | 22 | $2,987 | $136 |
| Short return visit (20+ min) | 32 | $2,615 | $71 |
| New patient visit (30+ min) | 16 | $1,816 | $114 |
2019: 5 services
| Return visit (30+ min) | 43 | $6,745 | $94 |
| Short return visit (20+ min) | 39 | $2,553 | $54 |
| New patient visit (45+ min) | 17 | $2,129 | $125 |
| Influenza vaccine split virus, preservative free | 15 | $854 | $53 |
| Administration of influenza virus vaccine | 14 | $303 | $20 |
2018: 3 services
| Short return visit (20+ min) | 18 | $1,505 | $68 |
| Influenza vaccine split virus, preservative free | 11 | $485 | $44 |
| Administration of influenza virus vaccine | 11 | $278 | $25 |
Medicaid work
$78,583 in 2018
Medicaid paid $78,583 for 1,037 billed services this clinician did in 2018, up to 121 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 536 | $73,951 |
| Short return visit (20+ min) | 256 | $2,786 |
| Short return visit | 84 | $1,728 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 130 | $80 |
| Screening test, pure tone, air only | 31 | $38 |
| 2018 | 1,037 | 5 | 121 | $78,583 |
Drugs they prescribed that Part D paid
$125,929
Pharmacies billed $125,929 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (24 of 1,413) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,274 generic and fewer than 11 brand-name prescriptions · $125,929 in drug cost · 50 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 12 | $12,902 | $1,075 |
| Atorvastatin | 107 | $1,458 | $14 |
| Gabapentin | 37 | $1,271 | $34 |
| Methylphenidate | 11 | $1,175 | $107 |
| Losartan | 59 | $904 | $15 |
See all 39 drugs
| Mounjaro | 12 | $12,902 | $1,075 |
| Atorvastatin | 107 | $1,458 | $14 |
| Gabapentin | 37 | $1,271 | $34 |
| Methylphenidate | 11 | $1,175 | $107 |
| Losartan | 59 | $904 | $15 |
| Diclofenac | 13 | $790 | $61 |
| Amlodipine Besylate | 73 | $699 | $10 |
| Metoprolol | 33 | $530 | $16 |
| Donepezil | 22 | $530 | $24 |
| Levothyroxine | 35 | $526 | $15 |
| Verapamil Er | 11 | $389 | $35 |
| Metformin | 18 | $387 | $21 |
| Fluoxetine | 15 | $380 | $25 |
| Lisinopril | 61 | $369 | $6 |
| Sertraline | 33 | $366 | $11 |
| Pantoprazole | 16 | $296 | $18 |
| Alendronate | 20 | $294 | $15 |
| Albuterol Sulfate Hfa | 14 | $267 | $19 |
| Omeprazole | 15 | $266 | $18 |
| Atenolol | 25 | $259 | $10 |
| Alfuzosin Hcl Er | 11 | $252 | $23 |
| Metformin Hcl Er | 23 | $242 | $11 |
| Hydralazine | 11 | $218 | $20 |
| Finasteride | 11 | $207 | $19 |
| Lovastatin | 16 | $205 | $13 |
| Simvastatin | 16 | $190 | $12 |
| Glipizide Er | 13 | $189 | $15 |
| Losartan-Hydrochlorothiazide | 11 | $173 | $16 |
| Azelastine | 11 | $170 | $15 |
| Hydrochlorothiazide | 22 | $154 | $7 |
| Furosemide | 24 | $153 | $6 |
| Allopurinol | 13 | $133 | $10 |
| Clonidine | 12 | $131 | $11 |
| Trazodone | 12 | $104 | $9 |
| Azithromycin | 17 | $102 | $6 |
| Metoprolol | 12 | $65 | $5 |
| Alprazolam | 14 | $44 | $3 |
| Zolpidem | 15 | $23 | $2 |
| Tramadol | 11 | $17 | $2 |
Year by year
| 2024 | 1,413 | 155 | 2% (24) | None | $125,929 |
| 2023 | 1,383 | 137 | 2% (23) | None | $95,051 |
| 2022 | 1,035 | 117 | 2% (21) | None | $53,632 |
| 2021 | 933 | 108 | 3% (24) | None | $63,601 |
| 2020 | 704 | 95 | 3% (19) | None | $40,795 |
| 2019 | 431 | 77 | 4% (16) | None | $28,855 |
| 2018 | 540 | 89 | 2% (13) | None | $26,158 |
| 2017 | 748 | 100 | 3% (25) | None | $37,178 |
| 2016 | 292 | 65 | 5% (13) | None | $7,412 |
| 2015 | 484 | 86 | 9% (41) | None | $18,808 |
| 2014 | 348 | 86 | 4% (14) | None | $13,037 |
| 2013 | 47 | 21 | None | None | $1,895 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Budesonide-Formoterol | 12 | $3,076 | $256 |
| Gabapentin | 66 | $1,298 | $20 |
| Atorvastatin | 83 | $1,188 | $14 |
| Verapamil Er | 19 | $1,058 | $56 |
| Losartan | 51 | $1,049 | $21 |
| Amlodipine Besylate | 81 | $896 | $11 |
| Diclofenac | 16 | $846 | $53 |
| Levothyroxine | 38 | $790 | $21 |
| Albuterol Sulfate Hfa | 20 | $676 | $34 |
| Pantoprazole | 24 | $635 | $26 |
| Alendronate | 34 | $500 | $15 |
| Hydralazine | 20 | $480 | $24 |
| Metoprolol | 31 | $469 | $15 |
| Fluticasone Propionate | 20 | $437 | $22 |
| Lisinopril | 53 | $407 | $8 |
| Sertraline | 35 | $378 | $11 |
| Omeprazole | 19 | $290 | $15 |
| Allopurinol | 16 | $277 | $17 |
| Ketoconazole | 11 | $264 | $24 |
| Fluoxetine | 12 | $259 | $22 |
| Potassium Chloride | 13 | $252 | $19 |
| Metformin Hcl Er | 14 | $203 | $15 |
| Donepezil | 13 | $199 | $15 |
| Atenolol | 24 | $186 | $8 |
| Furosemide | 28 | $183 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $157 | $14 |
| Simvastatin | 16 | $141 | $9 |
| Azithromycin | 19 | $140 | $7 |
| Rosuvastatin | 15 | $137 | $9 |
| Metformin | 11 | $137 | $12 |
| Zolpidem | 23 | $120 | $5 |
| Hydrochlorothiazide | 20 | $88 | $4 |
| Alprazolam | 21 | $80 | $4 |
| Tramadol | 12 | $53 | $4 |
| Cyclobenzaprine | 14 | $47 | $3 |
2022: 24 drugs
| Atorvastatin | 71 | $1,042 | $15 |
| Diclofenac | 15 | $804 | $54 |
| Levothyroxine | 34 | $781 | $23 |
| Gabapentin | 43 | $769 | $18 |
| Pantoprazole | 35 | $689 | $20 |
| Losartan | 48 | $657 | $14 |
| Lisinopril | 27 | $543 | $20 |
| Allopurinol | 24 | $519 | $22 |
| Fluticasone Propionate | 21 | $479 | $23 |
| Metformin Hcl Er | 15 | $469 | $31 |
| Amlodipine Besylate | 42 | $417 | $10 |
| Alendronate | 12 | $298 | $25 |
| Sertraline | 18 | $283 | $16 |
| Omeprazole | 20 | $282 | $14 |
| Cyclobenzaprine | 13 | $266 | $20 |
| Metoprolol | 15 | $225 | $15 |
| Simvastatin | 16 | $224 | $14 |
| Duloxetine | 13 | $223 | $17 |
| Zolpidem | 24 | $141 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $122 | $9 |
| Atenolol | 14 | $103 | $7 |
| Furosemide | 21 | $72 | $3 |
| Triamcinolone Acetonide | 15 | $65 | $4 |
| Alprazolam | 16 | $60 | $4 |
2021: 25 drugs
| Levothyroxine | 29 | $880 | $30 |
| Atorvastatin | 45 | $792 | $18 |
| Pantoprazole | 35 | $603 | $17 |
| Diclofenac | 15 | $455 | $30 |
| Metformin Hcl Er | 20 | $453 | $23 |
| Albuterol Sulfate Hfa | 12 | $442 | $37 |
| Lisinopril | 31 | $419 | $14 |
| Omeprazole | 22 | $414 | $19 |
| Gabapentin | 35 | $413 | $12 |
| Losartan | 32 | $401 | $13 |
| Fluticasone Propionate | 11 | $329 | $30 |
| Metoprolol | 12 | $283 | $24 |
| Allopurinol | 21 | $233 | $11 |
| Atenolol | 14 | $230 | $16 |
| Amlodipine Besylate | 27 | $217 | $8 |
| Simvastatin | 13 | $144 | $11 |
| Metformin | 13 | $118 | $9 |
| Cyclobenzaprine | 15 | $116 | $8 |
| Triamcinolone Acetonide | 16 | $93 | $6 |
| Ibuprofen | 13 | $74 | $6 |
| Hydrocodone-Acetaminophen | 15 | $68 | $5 |
| Alprazolam | 11 | $49 | $4 |
| Zolpidem | 14 | $41 | $3 |
| Clonazepam | 11 | $36 | $3 |
| Furosemide | 11 | $29 | $3 |
2020: 20 drugs
| Atorvastatin | 26 | $681 | $26 |
| Pregabalin | 12 | $659 | $55 |
| Pantoprazole | 23 | $509 | $22 |
| Metoprolol | 14 | $496 | $35 |
| Levothyroxine | 13 | $437 | $34 |
| Glipizide | 13 | $364 | $28 |
| Lisinopril | 30 | $339 | $11 |
| Amlodipine Besylate | 28 | $327 | $12 |
| Celecoxib | 11 | $300 | $27 |
| Losartan | 21 | $290 | $14 |
| Allopurinol | 21 | $242 | $12 |
| Gabapentin | 23 | $210 | $9 |
| Atenolol | 13 | $157 | $12 |
| Omeprazole | 11 | $155 | $14 |
| Fluoxetine | 12 | $138 | $11 |
| Metformin | 12 | $137 | $11 |
| Hydrocodone-Acetaminophen | 14 | $93 | $7 |
| Zolpidem | 17 | $66 | $4 |
| Hydrochlorothiazide | 13 | $65 | $5 |
| Alprazolam | 11 | $12 | $1 |
2019: 8 drugs
| Trulicity | 11 | $9,003 | $818 |
| Levothyroxine | 11 | $305 | $28 |
| Atorvastatin | 12 | $257 | $21 |
| Amlodipine Besylate | 29 | $215 | $7 |
| Metformin | 13 | $178 | $14 |
| Lisinopril | 14 | $137 | $10 |
| Zolpidem | 14 | $44 | $3 |
| Triamcinolone Acetonide | 12 | $35 | $3 |
2018: 15 drugs
| Levothyroxine | 25 | $602 | $24 |
| Atorvastatin | 22 | $354 | $16 |
| Pravastatin | 11 | $219 | $20 |
| Amlodipine Besylate | 29 | $215 | $7 |
| Losartan | 22 | $210 | $10 |
| Metformin | 29 | $200 | $7 |
| Clopidogrel | 15 | $193 | $13 |
| Gabapentin | 16 | $170 | $11 |
| Lisinopril | 29 | $166 | $6 |
| Fluticasone Propionate | 15 | $164 | $11 |
| Hydrochlorothiazide | 28 | $157 | $6 |
| Omeprazole | 17 | $146 | $9 |
| Metoprolol | 27 | $111 | $4 |
| Simvastatin | 19 | $96 | $5 |
| Glipizide | 13 | $67 | $5 |
2017: 17 drugs
| Levothyroxine | 58 | $818 | $14 |
| Metoprolol | 18 | $376 | $21 |
| Hydrocodone-Acetaminophen | 25 | $374 | $15 |
| Metformin | 44 | $310 | $7 |
| Gabapentin | 41 | $306 | $7 |
| Fluticasone Propionate | 18 | $265 | $15 |
| Hydrochlorothiazide | 50 | $236 | $5 |
| Omeprazole | 36 | $233 | $6 |
| Atorvastatin | 17 | $176 | $10 |
| Losartan | 22 | $136 | $6 |
| Amlodipine Besylate | 25 | $133 | $5 |
| Metoprolol | 22 | $132 | $6 |
| Lisinopril | 33 | $127 | $4 |
| Simvastatin | 20 | $117 | $6 |
| Glipizide | 16 | $117 | $7 |
| Alendronate | 13 | $108 | $8 |
| Furosemide | 11 | $52 | $5 |
2016: 7 drugs
| Metformin | 26 | $152 | $6 |
| Simvastatin | 19 | $125 | $7 |
| Omeprazole | 19 | $109 | $6 |
| Metoprolol | 11 | $73 | $7 |
| Lisinopril | 16 | $55 | $3 |
| Amlodipine Besylate | 12 | $50 | $4 |
| Gabapentin | 11 | $36 | $3 |
2015: 15 drugs
| Lantus | 12 | $3,099 | $258 |
| Hydrocodone-Acetaminophen | 32 | $762 | $24 |
| Levothyroxine | 23 | $505 | $22 |
| Diltiazem 24hr Cd | 11 | $312 | $28 |
| Losartan | 23 | $254 | $11 |
| Simvastatin | 18 | $205 | $11 |
| Hydrochlorothiazide | 49 | $204 | $4 |
| Metformin | 18 | $163 | $9 |
| Omeprazole | 20 | $151 | $8 |
| Amlodipine Besylate | 18 | $125 | $7 |
| Lisinopril | 22 | $105 | $5 |
| Alendronate | 13 | $102 | $8 |
| Metoprolol | 14 | $89 | $6 |
| Atenolol | 11 | $71 | $6 |
| Glipizide | 15 | $68 | $5 |
2014: 12 drugs
| Hydrocodone-Acetaminophen | 12 | $400 | $33 |
| Omeprazole | 14 | $321 | $23 |
| Simvastatin | 16 | $256 | $16 |
| Metformin | 21 | $191 | $9 |
| Levothyroxine | 12 | $155 | $13 |
| Amlodipine Besylate | 18 | $143 | $8 |
| Lisinopril | 13 | $138 | $11 |
| Losartan | 11 | $117 | $11 |
| Hydrochlorothiazide | 24 | $101 | $4 |
| Glipizide | 12 | $82 | $7 |
| Atenolol | 12 | $79 | $7 |
| Metoprolol | 16 | $44 | $3 |
Professional record
- NPI
- 1225342264
- Licence
- CA A 126396California A126396: Current · expires 2027-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 785 Morse Ave, Sunnyvale, CA, 94085
- NPI first listed
- 2010-08-02
- NPI last updated
- 2013-07-19
This is when the NPI record was last certified, not a medical board exam.